Thomas Flaten
Stock Analyst at Lake Street
(0.96)
# 3,493
Out of 4,791 analysts
38
Total ratings
29.73%
Success rate
-16.47%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCX OncoCyte | Initiates: Buy | $5 | $2.95 | +69.49% | 5 | Mar 28, 2025 | |
| OPTN OptiNose | Downgrades: Hold | $17 → $9 | $9.16 | -1.75% | 5 | Mar 20, 2025 | |
| CKPT Checkpoint Therapeutics | Downgrades: Hold | $7 → $4.1 | $4.04 | +1.49% | 5 | Mar 10, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $3.04 | +163.16% | 2 | Mar 7, 2025 | |
| EVAX Evaxion Biotech | Maintains: Buy | $35 → $6 | $1.69 | +255.03% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $3.56 | +152.81% | 2 | Jan 8, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $34 → $40 | $20.19 | +98.12% | 5 | Nov 5, 2024 | |
| DERM Journey Medical | Initiates: Buy | $9 | $6.24 | +44.23% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.67 | +345.77% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.55 | +331.37% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $23.78 | +5.13% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.64 | +54,445.45% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $3.96 | +102.02% | 1 | Jul 7, 2022 |
OncoCyte
Mar 28, 2025
Initiates: Buy
Price Target: $5
Current: $2.95
Upside: +69.49%
OptiNose
Mar 20, 2025
Downgrades: Hold
Price Target: $17 → $9
Current: $9.16
Upside: -1.75%
Checkpoint Therapeutics
Mar 10, 2025
Downgrades: Hold
Price Target: $7 → $4.1
Current: $4.04
Upside: +1.49%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.04
Upside: +163.16%
Evaxion Biotech
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $1.69
Upside: +255.03%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.56
Upside: +152.81%
Castle Biosciences
Nov 5, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $20.19
Upside: +98.12%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $6.24
Upside: +44.23%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.67
Upside: +345.77%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.55
Upside: +331.37%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $23.78
Upside: +5.13%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.64
Upside: +54,445.45%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $3.96
Upside: +102.02%